The largest purchase of all time was on 2013-11-12 and amounted to 6000 shares of BioCryst Pharmaceuticals, Inc. for $37,140.
The largest sale of all time was on 2021-09-10 and amounted to 74000 shares of BioCryst Pharmaceuticals, Inc. for $1.12M.
No biography is available at this moment.
| 2022-04-18 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | 5,000 0.0028% | $11.04 | $55,200 | +2.07% | ||
| 2022-02-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 5,000 0.0027% | $18.50 | $92,500 | -36.94% | |
| 2021-11-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 5,000 0.0028% | $12.27 | $61,350 | +10.95% | |
| 2021-09-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 5,000 0.0028% | $15.06 | $75,300 | -9.02% | |
| 2021-09-10 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 74,000 0.041% | $15.09 | $1.12M | -9.67% | |
| 2021-07-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 5,000 0.0028% | $15.69 | $78,450 | -9.02% | |
| 2021-05-24 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 13,334 0.0045% | $8.27 | $110,206 | +11.67% | |
| 2021-05-10 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | director | 14,000 0.0084% | $12.70 | $177,800 | +27.49% | |
| 2018-08-21 | Sale | Innoviva, Inc. INVA | Sr. VP & Chief Comm. Officer | 8,000 0.0079% | $14.11 | $112,840 | +3.84% | |
| 2018-05-21 | Sale | Innoviva, Inc. INVA | Sr. VP & Chief Comm. Officer | 8,000 0.0079% | $14.40 | $115,202 | +1.73% | |
| 2018-02-21 | Sale | Innoviva, Inc. INVA | Sr. VP & Chief Comm. Officer | 8,000 0.008% | $16.51 | $132,100 | -6.79% | |
| 2017-11-21 | Sale | Innoviva, Inc. INVA | Sr. VP & Chief Comm. Officer | 5,215 0.0049% | $13.26 | $69,145 | +9.21% | |
| 2013-11-12 | BioCryst Pharmaceuticals, Inc. BCRX | director | 6,000 0.0119% | $6.19 | $37,140 | +91.56% | ||
| 2013-03-05 | BioCryst Pharmaceuticals, Inc. BCRX | director | 6,000 0.0118% | $1.23 | $7,380 | +369.26% |